Baseline cystatin C measurement is a potent predictor of adverse cardiovascular outcomes following ACS: A PROVE IT - TIMI 22 analysis
Baseline cystatin C measurement is a potent predictor of adverse cardiovascular outcomes following ACS: A PROVE IT - TIMI 22 analysis. Circulation. 2006; 114(18):II-418.